Clearstead Advisors’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
928
-1,979
-68% -$359K ﹤0.01% 1047
2026
Q1
$388K Buy
2,907
+2,501
+616% +$398K ﹤0.01% 776
2025
Q4
$70.5K Sell
406
-2,204
-84% -$362K ﹤0.01% 1249
2025
Q3
$499K Buy
2,610
+2,317
+791% +$426K 0.01% 628
2025
Q2
$87.3K Buy
293
+167
+133% +$52.4K ﹤0.01% 1104
2025
Q1
$41.5K Buy
+126
New +$38.1K ﹤0.01% 1216
2024
Q3
Sell
-42
Closed -$12.5K 2086
2024
Q2
$12.5K Buy
+42
New +$14.3K ﹤0.01% 1500

Other funds holding MOH

Clearstead Advisors's MOH Position: Q2 2026 in Review

Clearstead Advisors reduced its Molina Healthcare (MOH) stake by 68% in Q2 2026, selling an estimated $359K and leaving 928 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

Clearstead Advisors first reported a position in MOH in Q2 2024 and has held it in 7 quarters since. The position peaked at $499K in Q3 2025. 601 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • Clearstead Advisors held 928 shares of Molina Healthcare worth $212K as of Q2 2026.
  • Clearstead Advisors sold 1,979 Molina Healthcare shares in Q2 2026, an estimated $359K.
  • Molina Healthcare made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1047 holding.
  • Clearstead Advisors first reported a position in Molina Healthcare in Q2 2024 and has held it in 7 quarters since.
  • Clearstead Advisors's Molina Healthcare position peaked at $499K in Q3 2025.
  • 601 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.